怕肾损用立普妥和区分阿乐pim.pptVIP

增龄性肾功能减退 每5 年减少6.7mL/min/1.73 m2 * * * 基线数据显示，eGFR15 的患者数在两组均为0，eGFR 15-29的患者比例在阿托伐他汀10mg和80mg组均为0.3%，eGFR 30-59的患者比例在阿托伐他汀10mg和80mg组分别为30.9%和32.9% This subanalysis of TNT compared the effects of atorvastatin 80 mg versus 10 mg on renal function in patients with CHD.1 Of the overall TNT population, 9656 patients had complete renal data using the MDRD (both baseline and postbaseline eGFR) and were included in this analysis of renal function.1 At baseline, chronic kidney disease (CKD) was present in 1505 patients (31.2%) in the atorvastatin 10 mg group and 1602 patients (33.2%) in the atorvastat